Table of Content

1 Markets
1.1 Product Definition
1.2 Inclusion and Exclusion

2 Scope of the Study
2.1 Key Questions Answered in the Report

3 Research Methodology
3.1 Data Source
3.1.1 Primary Data Source
3.1.1.1 Primary Research Methodology
3.1.2 Secondary Data Sources
3.1.2.1 Open Sources
3.2 Market Estimation Model
3.2.1 Criteria for Company Profiling

4 Market Overview
4.1 Emerging Applications of Gene Cloning Service
4.2 Addressable Market Size and Growth Potential
4.3 COVID-19 Impact on Global Gene Cloning Services Market
4.3.1 Impact on Market Size

5 Competitive Landscape
5.1 Corporate Strategies
5.1.1 Synergistic Activities
5.1.2 Acquisitions
5.1.3 Business Expansion Activities
5.2 Business Strategies
5.2.1 Service Launches
5.3 Market Share Analysis (by Company)
5.4 Growth-Share Analysis (by Company)

6 Industry Analysis
6.1 Legal Requirements and Framework in the U.S.
6.1.1 FDA Regulations
6.1.2 Legal Requirements and Framework in Europe
6.1.2.1 U.K.
6.1.2.2 Germany
6.1.3 Legal Requirements and Framework in Asia-Pacific
6.1.3.1 China
6.1.4 Japan
6.1.4.1 Pharmaceuticals and Medical Devices Agency (PMDA)

7 Market Dynamics
7.1 Overview
7.2 Impact Analysis
7.3 Market Drivers
7.3.1 Favorable Funding Scenario for Gene Synthesis and Cloning Services
7.3.2 Technological Advancement in Cloning and Sub Cloning Services
7.3.3 Rise in Synergistic Activities in Market
7.4 Market Restraints
7.4.1 Complications Associated with Large-Scale Production of Cloning Vectors
7.4.2 Lower Transfection Efficiency
7.5 Market Opportunities
7.5.1 Rise in Demand for Gene and Cloning Services
7.5.2 Limitation of Vectors or Plasmid
7.5.3 Development of New Economical Technologies and Services

8 Global Gene Cloning Services Market, by Service, $Million, 2020-2031
8.1 Overview
8.2 Gene Synthesis Service
8.3 Molecular Biology Service
8.3.1 PCR Cloning and Sub Cloning Service
8.3.2 Site-Directed Mutagenesis
8.3.3 Other Service
8.4 Custom Cloning Service
8.5 Other Service

9 Global Gene Cloning Services Market, by Gene Type, $Million, 2020-2031
9.1 Overview
9.2 Stranded Gene
9.3 Complex Gene
9.4 Other Gene Type

10 Global Gene Cloning Services Market, by Application, $Million, 2020-2031
10.1 Overview
10.1.1 Gene Synthesis
10.1.2 Gene Expression
10.1.3 Gene Therapy
10.1.4 Vaccine Research
10.1.5 Other

11 Global Gene Cloning Services Market, by End User, $Million, 2020-2031
11.1 Overview
11.1.1 Academic and Research Institutions
11.1.2 Clinical Laboratories
11.1.3 Pharmaceutical and Biotechnology Companies
11.1.4 Other End User

12 Global Gene Cloning Services Market, by Region, $Million, 2020-2031
12.1 Overview
12.2 North America
12.2.1 North America Gene Cloning Services Market (Service)
12.2.1.1 North America Gene Synthesis Service Market
12.2.1.2 North America Molecular Biology Service
12.2.1.3 North America Custom Cloning Service Market
12.2.1.4 North America Other Service Market
12.2.2 U.S.
12.2.3 Canada
12.3 Europe
12.3.1 Europe Gene Cloning Services Market (Service)
12.3.1.1 Europe Gene Synthesis Service Market
12.3.1.2 Europe Molecular Biology Service Market
12.3.1.3 Europe Custom Cloning Service Market
12.3.1.4 Europe Other Service Market
12.3.2 Germany
12.3.3 U.K.
12.3.4 France
12.3.5 Italy
12.3.6 Spain
12.3.7 Switzerland
12.3.8 Rest-of-Europe
12.4 Asia-Pacific
12.4.1 Asia-Pacific Gene Cloning Services Market (Service)
12.4.1.1 Asia-Pacific Gene Synthesis Service Market
12.4.1.2 Asia-Pacific Molecular Biology Service Market
12.4.1.3 Asia-Pacific Custom Cloning Service Market
12.4.1.4 Asia-Pacific Other Service Market
12.4.2 China
12.4.3 India
12.4.4 Japan
12.4.5 Australia
12.4.6 South Korea
12.4.7 Rest-of-Asia-Pacific
12.5 Latin America (LATAM)
12.5.1 Latin America (LATAM) Gene Cloning Services Market (Service)
12.5.1.1 Latin America (LATAM) Gene Synthesis Service Market
12.5.1.2 Latin America (LATAM) Molecular Biology Service Market
12.5.1.3 Latin America (LATAM) Custom Cloning Service Market
12.5.1.4 Latin America (LATAM) Other Service Market
12.5.2 Brazil
12.5.3 Mexico
12.5.4 Rest-of-Latin America
12.6 Rest-of-the-World (RoW)
12.6.1 Rest-of-the-World (RoW) Gene Cloning Services Market (Service)
12.6.1.1 Rest-of-the-World (RoW) Gene Synthesis Service Market
12.6.1.2 Rest-of-the-World (RoW) Molecular Biology Service Market
12.6.1.3 Rest-of-the-World (RoW) Custom Cloning Service Market
12.6.1.4 Rest-of-the-World (RoW) Other Service Market

13 Company Profiles
13.1 Overview
13.2 Thermo Fisher Scientific Inc.
13.2.1 Company Overview
13.2.2 Role of Thermo Fisher Scientific Inc. in the Global Gene Cloning Services Market
13.2.3 Key Customers of the Company
13.2.4 Key Competitors of the Company
13.2.5 Financials
13.2.6 Key Insights about the Financial Health of the Company
13.2.7 SWOT Analysis
13.3 Eurofins Scientific
13.3.1 Company Overview
13.3.2 Role of Eurofins Scientific in the Global Gene Cloning Services Market
13.3.3 Key Customers of the Company
13.3.4 Key Competitors of the Company
13.3.5 Financials
13.3.6 SWOT Analysis
13.4 GenScript
13.4.1 Company Overview
13.4.2 Role of GenScript in the Global Gene Cloning Services Market
13.4.3 Key Customers of the Company
13.4.4 Key Competitors of the Company
13.4.5 Financials
13.4.6 Key Insights about the Financial Health of the Company
13.4.7 SWOT Analysis
13.5 Merck KGaA
13.5.1 Company Overview
13.5.2 Role of Merck KGaA in the Global Gene Cloning Services Market
13.5.3 Key Customers of the Company
13.5.4 Key Competitors of the Company
13.5.5 Financials
13.5.6 Key Insights about the Financial Health of the Company
13.5.7 SWOT Analysis
13.6 Takara Bio Inc.
13.6.1 Company Overview
13.6.2 Role of Takara Bio Inc. in the Global Gene Cloning Services Market
13.6.3 Key Customers of the Company
13.6.4 Key Competitors of the Company
13.6.5 Financials
13.6.6 Key Insights about the Financial Health of the Company
13.6.7 SWOT Analysis
13.7 Charles River Laboratories
13.7.1 Company Overview
13.7.2 Role of Charles River Laboratories in the Global Gene Cloning Services Market
13.7.3 Key Customers of the Company
13.7.4 Key Competitors of the Company
13.7.5 Financials
13.7.6 SWOT Analysis
13.8 Lonza
13.8.1 Company Overview
13.8.2 Role of Lonza in the Global Gene Cloning Services Market
13.8.3 Key Customers of the Company
13.8.4 Key Competitors of the Company
13.8.5 Financials
13.8.6 SWOT Analysis
13.9 Sartorius AG
13.9.1 Company Overview
13.9.2 Role of Sartorius AG in the Global Gene Cloning Services Market
13.9.3 Key Customers of the Company
13.9.4 Key Competitors of the Company
13.9.5 Financials
13.9.6 SWOT Analysis
13.1 Creative Biogene
13.10.1 Company Overview
13.10.2 Role of Creative Biogene in the Global Gene Cloning Services Market
13.10.3 Key Customers of the Company
13.10.4 Key Competitors of the Company
13.10.5 SWOT Analysis
13.11 Cellecta, Inc.
13.11.1 Company Overview
13.11.2 Role of Cellecta, Inc., in the Global Gene Cloning Services Market
13.11.3 Key Customers of the Company
13.11.4 Key Competitors of the Company
13.11.5 SWOT Analysis
13.12 Synbio Technologies
13.12.1 Company Overview
13.12.2 Role of Synbio Technologies in the Global Gene Cloning Services Market
13.12.3 Key Customers of the Company
13.12.4 Key Competitors of the Company
13.12.5 SWOT Analysis
13.13 TransGen Biotech Co., Ltd.
13.13.1 Company Overview
13.13.2 Role of TransGen Biotech Co., Ltd. in the Global Gene Cloning Services Market
13.13.3 Key Customers of the Company
13.13.4 Key Competitors of the Company
13.13.5 SWOT Analysis
13.14 Dobuss (Canvax)
13.14.1 Company Overview
13.14.2 Role of Dobuss (Canvax) in the Global Gene Cloning Services Market.
13.14.3 Key Customers of the Company
13.14.4 Key Competitors of the Company
13.14.5 SWOT Analysis
13.15 Azenta US, Inc.
13.15.1 Company Overview
13.15.2 Role of Azenta US, Inc. in the Global Gene Cloning Services Market
13.15.3 Key Customers of the Company
13.15.4 Key Competitors of the Company
13.15.5 Financials
13.15.6 Key Insights about the Financial Health of the Company
13.15.7 SWOT Analysis
13.16 Macrogen, Inc.
13.16.1 Company Overview
13.16.2 Role of Macrogen, Inc. in the Global Gene Cloning Services Market
13.16.3 Key Customers of the Company
13.16.4 Key Competitors of the Company
13.16.5 SWOT Analysis
13.17 Codex DNA, Inc.
13.17.1 Company Overview
13.17.2 Role of Codex DNA, Inc. in the Global Gene Cloning Services Market
13.17.3 Key Customers of the Company
13.17.4 Key Competitors of the Company
13.17.5 SWOT Analysis
List of Figures
Figure 1: Annual NIH Funding in Human Genomics Research, $Billion, FY2013-FY2020
Figure 2: Global Gene Cloning Services: Market Dynamics
Figure 3: Share of Key Market Strategies and Developments, January 2018-December 2021
Figure 4: Global Gene Cloning Services Market Snapshot, $Million, 2020-2031
Figure 5: Global Gene Cloning Services Market (by Service), $Million, 2020 Vs. 2031
Figure 6: Global Gene Cloning Services Market (by Gene Type), $Million, 2020 Vs. 2031
Figure 7: Global Gene Cloning Services Market (by Application), $Million, 2020 Vs. 2031
Figure 8: Global Gene Cloning Services Market (by End User), $Million, 2020 Vs. 2031
Figure 9: Global Gene Cloning Services Market (by Region), $Million, 2020 Vs. 2031
Figure 10: Figure 10: Global Gene Cloning Services Market Segmentation
Figure 11: Global Gene Cloning Services Market Research Methodology
Figure 12: Bottom-Up Approach (Segment-Wise Analysis)
Figure 13: Top-Down Approach (Segment-Wise Analysis)
Figure 14: Classification of Gene Cloning Service
Figure 15: Personalized Care for Cancer Patients
Figure 16: Classification of Gene Cloning Service (by Service)
Figure 17: Global Gene Cloning Services Market, $Million, 2020-2031
Figure 18: Pre-COVID-19 and Post-COVID-19 Scenario of Global Gene Cloning Services Market, $Million, 2019-2025
Figure 19: Impact of COVID-19 on Gene Cloning Services Market
Figure 20: Share of Key Developments and Strategies, January 2018-January 2022
Figure 21: Share of Synergistic Activities (by Company), January 2018-January 2022
Figure 22: Share of Acquisition (by Company), January 2018-January 2022
Figure 23: Share of Business Expansion Activities (by Company), January 2018-January 2022
Figure 24: Share of Services Launches (by Company), January 2018-January 2022
Figure 25: Market Share Analysis for Global Gene Cloning Services Market, $Million, 2019 and 2020
Figure 26: Growth-Share Analysis of Global Gene Cloning Services Market (by Company), 2019-2020
Figure 27: Responsibilities of the National Medical Products Administration (NMPA)
Figure 28: Global Gene Cloning Services Market Dynamics
Figure 29: Troubleshooting Guide for Cloning
Figure 30: Global Gene Cloning Services Market (by Service)
Figure 31: Share of Global Gene Cloning Services Market (by Service), $Million, 2020 and 2031
Figure 32: Global Gene Cloning Services Market (Gene Synthesis Service), $Million, 2020-2031
Figure 33: Global Gene Cloning Services Market (Molecular Biology Service), $Million, 2020-2031
Figure 34: Figure 34: Global Gene Cloning Services Market (PCR Cloning and Sub Cloning Service, by Molecular Biology Service), $Million, 2020-2031
Figure 35: Global Gene Cloning Services Market (Site-Directed Mutagenesis, by Molecular Biology Service), $Million, 2020-2031
Figure 36: Global Gene Cloning Services Market (Other Service, by Molecular Biology Service), $Million, 2020-2031
Figure 37: Global Gene Cloning Services Market (Custom Cloning Service), $Million, 2020-2031
Figure 38: Figure 38: Global Gene Cloning Services Market (Other Service), $Million, 2020-2031
Figure 39: Global Gene Cloning Services Market (by Gene Type)
Figure 40: Share of Global Gene Cloning Services Market (by Gene Type), $Million, 2020 and 2031
Figure 41: Global Gene Cloning Services Market (Stranded Gene), $Million, 2020-2031
Figure 42: Global Gene Cloning Services Market (Complex Gene), $Million, 2020-2031
Figure 43: Global Gene Cloning Services Market (Other Gene Type), $Million, 2020-2031
Figure 44: Share of Global Gene Cloning Services Market (by Application), $Million, 2020 and 2031
Figure 45: Global Gene Cloning Services Market (Gene Synthesis), $Million, 2020-2031
Figure 46: Global Gene Cloning Services Market (Gene Expression), $Million, 2020-2031
Figure 47: Global Gene Cloning Services Market (Gene Therapy), $Million, 2020-2031
Figure 48: Global Gene Cloning Services Market (Vaccine Research) $Million, 2021-2031
Figure 49: Global Gene Cloning Services Market (Other), $Million, 2021-2031
Figure 50: Share of Global Gene Cloning Services Market (by End User), $Million, 2020 and 2031
Figure 51: Global Gene Cloning Services Market (Academic and Research Institutions), $Million, 2020-2031
Figure 52: Global Gene Cloning Services Market (Clinical Laboratories), $Million, 2020-2031
Figure 53: Global Gene Cloning Services Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2031
Figure 54: Global Gene Coning Services Market (Other End User), $Million, 2020-2031
Figure 55: Global Gene Cloning Services Market (by Region), $Million, 2020-2031
Figure 56: Share of North America Gene Cloning Services Market Revenue (by Country), $Million, 2020 and 2031
Figure 57: North America: Market Dynamics
Figure 58: Share of North America Gene Cloning Services Market Revenue (by Service), $Million, 2020 and 2031
Figure 59: North America Gene Synthesis Service Market, $Million, 2020-2031
Figure 60: North America Molecular Biology Service Market, $Million, 2020-2031
Figure 61: North America Custom Cloning Service Market, $Million, 2020-2031
Figure 62: North America Other Service Market, $Million, 2020-2031
Figure 63: U.S. Gene Cloning Services Market, $Million, 2020-2031
Figure 64: Canada Gene Cloning Services Market, $Million, 2020-2031
Figure 65: Europe Gene Cloning Services Market (by Country), $Million, 2020 and 2031
Figure 66: Europe: Market Dynamics
Figure 67: Europe Gene Cloning Services Market (by Service), $Million, 2020 and 2031
Figure 68: Europe Gene Synthesis Service Market, $Million, 2020-2031
Figure 69: Europe Molecular Biology Service Market, $Million, 2020-2031
Figure 70: Europe Custom Cloning Service Market, $Million, 2020-2031
Figure 71: Europe Other Service Market, $Million, 2020-2031
Figure 72: Germany Gene Cloning Services Market, $Million, 2020-2031
Figure 73: U.K. Gene Cloning Services Market, Million, 2020-2031
Figure 74: France Gene Cloning Services Market, $Million, 2020-2031
Figure 75: Italy Gene Cloning Services Market, $Million, 2020-2031
Figure 76: Spain Gene Cloning Services Market, $Million, 2020-2031
Figure 77: Switzerland Gene Cloning Services Market, $Million, 2020-2031
Figure 78: Rest-of-Europe Gene Cloning Services Market, $Million, 2020-2031
Figure 79: Asia-Pacific: Market Dynamics
Figure 80: Asia-Pacific Gene Cloning Services Market (by Country), $Million, 2020 and 2031
Figure 81: Asia-Pacific Gene Cloning Services Market (by Service), $Million, 2020 and 2031
Figure 82: Asia-Pacific Gene Synthesis Service Market, $Million, 2020-2031
Figure 83: Asia-Pacific Molecular Biology Service Market, $Million, 2020-2031
Figure 84: Asia-Pacific Custom Cloning Service Market, $Million, 2020-2031
Figure 85: Asia-Pacific Other Service Market, $Million, 2020-2031
Figure 86: China Gene Cloning Services Market, $Million, 2020-2031
Figure 87: India Gene Cloning Services Market, $Million, 2020-2031
Figure 88: Japan Gene Cloning Services Market, $Million, 2020-2031
Figure 89: Australia Gene Cloning Services Market, $Million, 2020-2031
Figure 90: South Korea Gene Cloning Services Market, $Million, 2020-2031
Figure 91: Rest-of-Asia-Pacific Gene Cloning Services Market, $Million, 2020-2031
Figure 92: Latin America: Market Dynamics
Figure 93: Latin America Gene Cloning Services Market (by Country), $Million 2020-2031
Figure 94: Latin America Gene Cloning Services Market (by Service), $Million 2020 and 2031
Figure 95: Latin America (LATAM) Gene Synthesis Service Market, $Million, 2020-2031
Figure 96: Latin America (LATAM) Molecular Biology Service Market, $Million, 2020-2031
Figure 97: Latin America (LATAM) Custom Cloning Service Market, $Million, 2020-2031
Figure 98: Latin America (LATAM) Other Service Market, $Million, 2020-2031
Figure 99: Brazil Gene Cloning Services Market, $Million, 2020-2031
Figure 100: Mexico Gene Cloning Services Market, $Million, 2020-2031
Figure 101: Rest-of-Latin America Gene Cloning Services Market, $Million, 2020-2031
Figure 102: Rest-of-the-World Gene Cloning Services Market, $Million, 2020-2031
Figure 103: Rest-of-the-World Gene Cloning Services Market (by Service), $Million, 2020 and 2031
Figure 104: Rest-of-the-World (RoW) Gene Synthesis Service Market, $Million, 2020-2031
Figure 105: Rest-of-the-World (RoW) Molecular Biology Service Market, $Million, 2020-2031
Figure 106: Rest-of-the-World (RoW) Custom Cloning Service Market, $Million, 2020-2031
Figure 107: Rest-of-the-World (RoW) Other Service Market, $Million, 2020-2031
Figure 108: Share of Key Companies Profiled
Figure 109: Thermo Fisher Scientific, Inc.: Service Portfolio
Figure 110: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
Figure 111: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), $Million, 2018-2020
Figure 112: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018-2020
Figure 113: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
Figure 114: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 115: Eurofins Scientific: Service Portfolio
Figure 116: Eurofins Scientific: Overall Financials, $Million, 2018-2020
Figure 117: Eurofins Scientific: Revenue (by Region), $Million, 2018-2020
Figure 118: Eurofins Scientific: SWOT Analysis
Figure 119: GenScript: Service Portfolio
Figure 120: GenScript: Overall Financials, $Million, 2018-2020
Figure 121: GenScript: Revenue (by Business Segment), $Million, 2018-2020
Figure 122: GenScript: Revenue (by Region), $Million, 2018-2020
Figure 123: GenScript: R&D Expenditure, $Million, 2018-2020
Figure 124: GenScript: SWOT Analysis
Figure 125: Merck KGaA: Service Portfolio
Figure 126: Merck KGaA: Overall Financials, $Million, 2019-2021
Figure 127: Merck KGaA: Revenue (by Business Segment), $Million, 2019-2021
Figure 128: Figure 123 Merck KGaA: Revenue (by Region), $Million, 2019-2021
Figure 129: Merck KGaA: R&D Expenditure, $Million, 2019-2021
Figure 130: Merck KGaA: SWOT Analysis
Figure 131: Takara Bio Inc.: Service Portfolio
Figure 132: Takara Bio Inc.: Overall Financials, $Million, 2018-2020
Figure 133: Takara Bio Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 134: Takara Bio Inc.: Revenue (by Region), $Million, 2018-2020
Figure 135: Takara Bio Inc.: R&D Expenditure, $Million, 2018-2021
Figure 136: Takara Bio Inc.: SWOT Analysis
Figure 137: Charles River Laboratories Service Portfolio
Figure 138: Charles River Laboratories: Overall Financials, $Million, 2018-2020
Figure 139: Charles River Laboratories: Revenue (by Business Segment), $Million, 2018-2020
Figure 140: Charles River Laboratories.: Revenue (by Region), $Million, 2018-2020
Figure 141: Charles River Laboratories: SWOT Analysis
Figure 142: Lonza: Service Portfolio
Figure 143: Lonza: Overall Financials, $Million, 2019-2021
Figure 144: Lonza: Revenue (by Business Segment), $Million, 2019-2021
Figure 145: Lonza: SWOT Analysis
Figure 146: Sartorius AG: Service Portfolio
Figure 147: Sartorius AG: Overall Financials, $Million, 2019-2021
Figure 148: Sartorius AG: Revenue (by Business Segment), 2019-2021
Figure 149: Sartorius AG: Revenue (by Region), $Million, 2019-2021
Figure 150: Sartorius AG: SWOT Analysis
Figure 151: Creative Biogene: Service Portfolio
Figure 152: Creative Biogene.: SWOT Analysis
Figure 153: Cellecta, Inc.: Service Portfolio
Figure 154: Cellecta, Inc.: SWOT Analysis
Figure 155: Synbio Technologies: Service Portfolio
Figure 156: Synbio Technologies: SWOT Analysis
Figure 157: TransGen Biotech Co., Ltd.: Service Portfolio
Figure 158: TransGen Biotech Co., Ltd.: SWOT Analysis
Figure 159: Dobuss (Canvax): Service Portfolio
Figure 160: Dobuss (Canvax): SWOT Analysis
Figure 161: Azenta US, Inc.: Service Portfolio
Figure 162: Azenta US, Inc.: Overall Financials, $Million, 2018-2020
Figure 163: Azenta US, Inc.: Revenue (by Business Segment), $Million, 2018-2020
Figure 164: Azenta US, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 165: Azenta US, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 166: Azenta US, Inc.: SWOT Analysis
Figure 167: Macrogen, Inc.: Service Portfolio
Figure 168: Macrogen, Inc.: SWOT Analysis
Figure 169: Codex DNA, Inc.: Service Portfolio
Figure 170: Codex DNA, Inc.: SWOT Analysis
List of Tables
Table 1: COVID-19 Impact on Global Gene Cloning Services Market
Table 2: Products Launched by Various Key Players for Gene Cloning Services Research
Table 3: Companies/Institute Offering Research Grants
Table 4: Synergistic Activities Undertaken by Companies in the Global Gene Cloning Services Market
Table 5: Efficiency Rate in the Global Gene Cloning Services Market
Table 6: Companies Expanding Business in Global Gene Cloning Services Market
Table 7: Companies Offering Gene Cloning Services in the Market
Table 8: List of Companies Providing Gene Synthesis Service
Table 9: List of Companies Providing Molecular Biology Service
Table 10: List of Companies Providing Custom Cloning Service
Table 11: List of Companies Providing Other Service